VIM and prostate cancer: Our overall results recommended that both aPKCs are critical components in Vimentin dynamics in which they are involved in the phosphorylation of Vimentin at Ser33, Ser39 and Ser56 to significantly activate Vimentin, thereby leading to the disassembly of VIF to support prostate cancer cell metastasis.